Protocol Ledger

Federal / Public Agency · Consolidated Sponsor Hub

Anhui Provincial Hospital: Clinical Trials & FDA Approval Profile

Anhui Provincial Hospital (Global / Institutional) sponsors 31 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 18 active protocols (13 recruiting now), 3 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)0.0%
Median Closed Enrollment vs National (145 pts)57 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Anhui Provincial Hospital
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)31
Active Pipeline (Recruiting Now)18 (13)
Completed vs Stopped Early3 / 0 (0.0%)
Median Closed Actual Enrollment57 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Anhui Provincial Hospital
Hospital Research SiteLocationShared Protocols
Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei2
The First Affiliated Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang2
The first affiliated hospital of Zhengzhou UniversityZhengzhou, Henan2

Explore interactive annual charts and M&A subsidiary rollups in the Anhui Provincial Hospital Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI